Marini et al. identified CD10 as a cell surface marker that distinguishes T cell suppressive from T cell stimulatory neutrophils in the peripheral blood of cancer and systemic lupus erythematosus (SLE) patients [96]. This evidence concerns the gene MME and cancer.